- Trials with a EudraCT protocol (116)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
116 result(s) found for: Resting State.
Displaying page 1 of 6.
EudraCT Number: 2009-013069-24 | Sponsor Protocol Number: CRC/2008/03 | Start Date*: 2010-02-04 |
Sponsor Name:AZIENDA OSPEDALIERA - CENTRO RICERCHE CLINICHE DI VERONA | ||
Full Title: A double blind, single dose, randomized, 2-way crossover, placebo controlled study to set-up the resting state test in 10 healthy subjects | ||
Medical condition: NA, Set-up model study | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004875-11 | Sponsor Protocol Number: CAMG334AIT03 | Start Date*: 2019-05-29 | |||||||||||
Sponsor Name:NOVARTIS FARMA S.P.A. | |||||||||||||
Full Title: A RandomizEd, double-blind, cross-over Study to assess Erenumab effecT on BRAIN networks function and structure in comparison to placebo in episodic migraine patients (RESET BRAIN) | |||||||||||||
Medical condition: Episodic migraine | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022772-31 | Sponsor Protocol Number: 20100812v2 | Start Date*: 2011-02-09 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Psychiatrie und Psychotherapie | |||||||||||||
Full Title: Brain Network Dysfunction as a Model for Schizophrenia: Connectivity Alterations using Ketamine and pharmacological Magnetic Resonance Imaging | |||||||||||||
Medical condition: Quantify changes of resting-state functional connectivity in response to Esketamine in healthy volunteers. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000841-28 | Sponsor Protocol Number: DC2017DECREASE01 | Start Date*: 2017-08-14 |
Sponsor Name:VU University Medical Center | ||
Full Title: Combined effects of SGLT2 inhibition and GLP-1 receptor agonism on food intake, body weight and central satiety and reward circuits in obese T2DM patients | ||
Medical condition: Type 2 diabetes mellitus Obesity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004509-30 | Sponsor Protocol Number: 012020 | Start Date*: 2021-05-13 | |||||||||||
Sponsor Name:INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON | |||||||||||||
Full Title: A prospective structural, diffusion and connectomics MRI study on migraine patients treated with Fremanezumab | |||||||||||||
Medical condition: MIGRAINE | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002386-18 | Sponsor Protocol Number: 11-185/CAIAC | Start Date*: 2016-03-15 |
Sponsor Name:RWTH Aachen Clinical Trials Center Aachen (CTC-A) | ||
Full Title: Network connectivity and inhibitory control under atomoxetin challenge - A pharamacological "resting state" and "inhibitory task" fMRI study in patients with ADHD | ||
Medical condition: Patients with Attention-Deficit/Hyperactivity Disorders (ADHD) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-000426-62 | Sponsor Protocol Number: CHDR1203-E | Start Date*: 2013-04-10 | ||||||||||||||||
Sponsor Name:Centre for Human Drug Research | ||||||||||||||||||
Full Title: A randomized, double blind, placebo-controlled crossover study to investigate the effects of a selective serotonergic reuptake inhibitor on resting state fMRI in healthy volunteers. | ||||||||||||||||||
Medical condition: healthy volunteers 'depression, anxiety' | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000148-24 | Sponsor Protocol Number: 1 | Start Date*: 2018-06-14 |
Sponsor Name:Norwegian University of Science and Technology | ||
Full Title: Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer’s disease: the ExPlas Study | ||
Medical condition: Early Alzheimer's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002848-24 | Sponsor Protocol Number: IFT2019 | Start Date*: 2020-03-06 |
Sponsor Name:GIGA-Consciousness Thematic Unit, Anesthesia and Intensive Care Laboratory, Liege University | ||
Full Title: Brain functional signature of connected consciousness under general anesthesia using the isolated forearm technique | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000908-15 | Sponsor Protocol Number: IMI2-PainCare-BioPain-RCT4 | Start Date*: 2019-09-24 | |||||||||||
Sponsor Name:Aarhus University | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, cross-over trial in healthy subjects to investigate the effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processing observed by... | |||||||||||||
Medical condition: Healthy volunteers (intended indication: pain) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003570-89 | Sponsor Protocol Number: 37559 | Start Date*: 2011-12-02 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: The effect of interferon beta-1a treatment on functional adaptation in Multiple Sclerosis (MS) | |||||||||||||
Medical condition: Multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003102-10 | Sponsor Protocol Number: modafinil01 | Start Date*: 2009-01-23 |
Sponsor Name:fonds NutsOhra | ||
Full Title: The effect of modafinil on fatigue, cognition and functional connectivity in low-grade glioma patients: a double-blind randomized trial. | ||
Medical condition: fatigue in low-grade glioma patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003280-38 | Sponsor Protocol Number: PSY-NIL-0006 | Start Date*: 2016-05-04 | |||||||||||
Sponsor Name:Medical University of Vienna | |||||||||||||
Full Title: Positron Emission Tomography assessment of Ketamine Binding of the Serotonin Transporter and its Relevance for Rapid Antidepressant Response | |||||||||||||
Medical condition: 20 patients with severe unipolar depression (structured clinical interview for DSM-IV and the 17-item Hamilton Depression Rating Scale), also 20 age and sex matched healthy controls. plus 12 HC f... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003557-21 | Sponsor Protocol Number: LixiBrain01 | Start Date*: 2019-02-06 | |||||||||||
Sponsor Name:University Hospital Tuebingen | |||||||||||||
Full Title: Effect of insulin glargine and lixisenatide versus insulin glargine on brain insulin sensitivity in patients with type 2 diabetes | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003120-17 | Sponsor Protocol Number: PDY16963 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Genzyme Corporation | |||||||||||||
Full Title: A 3-part study to evaluate the efficacy and safety of venglustat in combination with Cerezyme in adult and pediatric patients with Gaucher disease Type 3 (GD3) with open-label long-term treatment | |||||||||||||
Medical condition: Gaucher disease type 3 | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) DE (Prematurely Ended) HU (Prematurely Ended) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001719-19 | Sponsor Protocol Number: 2016:1 | Start Date*: 2016-07-25 |
Sponsor Name:Uppsala University | ||
Full Title: Selecitve progesterone receptor modulators for treatment of premenstrual dysphoric disorder. A randomized, double-blind, placebo controlled study. | ||
Medical condition: Premenstrual dysphoric disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003273-18 | Sponsor Protocol Number: RC31-15-7837 | Start Date*: 2016-11-14 |
Sponsor Name:University Hospital of Toulouse | ||
Full Title: Effects of intranasal administrations of oxytocin on beahvioural troubles, hyperphagia and social skills in children with Prader-Willi syndrome aged from 3 to 12 years. | ||
Medical condition: Prader-Willi Syndrom | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001217-25 | Sponsor Protocol Number: 2016-001217-25 | Start Date*: 2016-09-07 |
Sponsor Name:Uppsala University | ||
Full Title: Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) | ||
Medical condition: Premenstrual Dysphoric Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003571-17 | Sponsor Protocol Number: CY6022 | Start Date*: 2021-08-11 | |||||||||||
Sponsor Name:Cytokinetics, Inc. | |||||||||||||
Full Title: An Open-Label Study of CK-3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy (HCM) and Left Ventricular Outflow Tract Obstruction. | |||||||||||||
Medical condition: obstructive hypertrophic cardiomyopathy (oHCM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) IT (Ongoing) NL (Ongoing) HU (Ongoing) PL (Ongoing) DE (Ongoing) DK (Ongoing) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002663-10 | Sponsor Protocol Number: SSAT049 | Start Date*: 2012-11-12 |
Sponsor Name:St Stephen's AIDS Trust | ||
Full Title: A phase IV, open-label single-arm study investigating the pharmacokinetics and pharmacodynamics of the antiretroviral combination of rilpivirine and ritonavir-boosted darunavir in therapy-naive HIV... | ||
Medical condition: HIV-1 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.